Valuation: Dr. Reddy's Laboratories Limited

Market Cap 984B 10.28B 8.81B 8.22B 7.54B 14.17B 14.44B 97.46B 37.99B 493B 38.62B 37.78B 1,633B P/E 2027 *
26.1x
P/E 2028 * 20.3x
Enterprise Value 952B 9.95B 8.52B 7.95B 7.3B 13.71B 13.98B 94.34B 36.77B 477B 37.38B 36.56B 1,580B EV / Sales 2027 *
2.71x
EV / Sales 2028 * 2.37x
Free-Float
69.71%
Yield 2027 *
0.65%
Yield 2028 * 0.71%
1 day-0.54%
1 week-2.25%
Current month+2.39%
1 month-2.61%
3 months-10.87%
6 months-10.10%
Current year-7.56%
1 week 1,152.8
Extreme 1152.8
1,201.75
1 month 1,080.05
Extreme 1080.05
1,207.9
Current year 1,080.05
Extreme 1080.05
1,414.4
1 year 1,080.05
Extreme 1080.05
1,414.4
3 years 1,025.9
Extreme 1025.9
1,420.2
5 years 731
Extreme 731
1,420.2
10 years 377.6
Extreme 377.6
1,420.2
Manager TitleAgeSince
Chief Executive Officer 59 01/07/2019
Director of Finance/CFO - 01/08/2024
Chief Operating Officer - -
Director TitleAgeSince
Chairman 58 13/05/2014
Chairman 65 02/04/2013
Director/Board Member 65 25/10/2018
Date Insider Type Main position Quantity % Market Cap.
18/12/25 Other

Chairman

85,738,125 10.2732%
18/12/25 Other

Director

12,717,090 1.5238%
18/12/25 Other

Director

27,618,385 3.3092%
Change 5-day change 1-year change 3-year change Capi.($)
-0.54%-2.25%-7.96%-0.56% 10.28B
-2.81%+2.93%+76.40%+127.73% 1,109B
-2.21%+2.02%+49.50%+55.01% 644B
-1.56%+4.39%+25.19%+74.39% 463B
-1.25%+3.44%+39.92%+44.44% 371B
-0.96%+2.29%+21.76%+39.16% 301B
-0.49%+5.04%-0.08%+12.78% 256B
-1.95%+3.80%+46.31%+65.66% 234B
+0.04%+0.48%-16.85%-53.04% 205B
-2.82%+3.84%+20.81%+89.04% 178B
Average -0.48%+2.50%+25.50%+45.46% 377.14B
Weighted average by Cap. -0.17%+3.24%+42.60%+69.86%

Financials

2027 *2028 *
Net sales 352B 3.68B 3.15B 2.94B 2.7B 5.07B 5.17B 34.85B 13.59B 176B 13.81B 13.51B 584B 393B 4.1B 3.51B 3.28B 3.01B 5.65B 5.77B 38.9B 15.16B 197B 15.41B 15.08B 652B
Net income 37.22B 389M 333M 311M 285M 536M 546M 3.69B 1.44B 18.65B 1.46B 1.43B 61.76B 48.99B 512M 438M 409M 375M 705M 719M 4.85B 1.89B 24.55B 1.92B 1.88B 81.28B
Net Debt -31.58B -330M -283M -264M -242M -455M -464M -3.13B -1.22B -15.83B -1.24B -1.21B -52.4B -51.62B -539M -462M -431M -395M -743M -758M -5.11B -1.99B -25.87B -2.03B -1.98B -85.64B
Logo Dr. Reddy's Laboratories Limited
Dr. Reddy’s Laboratories Limited is an India-based pharmaceutical company. Its products and services are spread across its core businesses of active pharmaceutical ingredients (APIs), generics, branded generics, biosimilars and over-the-counter (OTC) pharmaceutical products. It works in the areas of gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology. Its segments consist of Global Generics; Pharmaceutical Services and Active Ingredients (PSAI), and Others. The Global Generics segment consists of the Company's business of manufacturing and marketing prescription and over-the-counter finished pharmaceutical products ready for consumption by the patient, marketed under a brand name (branded formulations) or as generic finished dosages with therapeutic equivalence to branded formulations (generics). The Pharmaceutical Services and Active Ingredients segment consists of the Company's business of manufacturing and marketing APIs and intermediates.
Employees
27,527
Date Price Change Volume
21/08/26 INR 1,175.00 -0.54% 28,730
20/08/26 INR 1,181.35 +0.88% 52,583
19/08/26 INR 1,171.00 -0.80% 71,049
18/08/26 INR 1,180.50 -0.96% 36,595
17/08/26 INR 1,192.00 -0.83% 164,076
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
39
Last Close Price
1,181.35INR
Average target price
1,265.77INR
Spread / Average Target
+7.15%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. DRREDDY Stock